Georgetown University Medical Center

Two agents deliver knockout punches to Ewing sarcoma

When combined with an already FDA-approved chemotherapy, a novel agent developed by researchers at Georgetown Lombardi Comprehensive Cancer Center, appears to halt the ability of Ewing sarcoma to grow and progress.

Oct 03, 2017
popularity40 comments 0